Stay updated with breaking news from Sharon Barr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
--Next-generation obesity company with potential best- and first-in-class assets launched by Versant Ventures-- --Emerges from stealth with $30 million in Series A financing and a strategic collaboration
Investor Day 2024 Unlocking growth to 2030 and beyond Speaker biographies Pascal Soriot ...
Amgen and AstraZeneca have reported data from a trial that showed the effectiveness of their asthma drug Tezspire in certain patients with COPD.
Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease. The Phase IIa COURSE trial was a...
WILMINGTON, Del.--(BUSINESS WIRE)--May 19, 2024--